Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
deals
life sciences
national blog main
national top stories
new york blog main
2
×
san francisco blog main
startups
vc
2
×
armo biosciences
autoimmune
avalon ventures
azacitidine
beta-thalassemia
boston
boston top stories
cancer
coi pharmaceuticals
correlation ventures
crohn's disease
cytokines
dacogen
decitabine
dna
drug development
eli lilly
epigenetics
epizyme
farydak
flagship pioneering
fulcrum therapeutics
fundraising
gvhd
immune checkpoint
innovation
insulated genomic domains
ipo
jay lichter
joseph leveque
What
drugs
2
×
advance
aims
approach
based
biology
biotech
called
company
cytokine
debuts
developing
enhanced
epigenetic
epigenetics
field
files
flagship’s
initial
ipo
laying
medicines
money
morning
new
offering
omega
plans
public
raise
research
san
startup
step
suite
synthetic
synthorx
therapeutics
touting
Language
unset
Current search:
xconomy.com
×
drugs
×
vc
×
" new york blog main "
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs